Matrix metalloproteases in vernal keratoconjunctivitis, nasal polyps and allergic asthma

Clinical and Experimental Allergy

Volumn 37, Issue 6, 2007, Pages 872-879

  Leonardi, A ^a,c   Brun, P ^a   Di Stefano, A ^b   Motterle, L ^a   Abatangelo, G ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b IRCCS   (Italy)

^c NONE   (Italy)

Author keywords

Collagen; MMP; Nasal polyps; Tissue remodelling; Vernal keratoconjunctivitis

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; MATRIX METALLOPROTEINASE; METALLOPROTEINASE; METALLOPROTEINASE 13; METALLOPROTEINASE 9; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALLERGIC ASTHMA; ARTICLE; BRONCHUS BIOPSY; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONJUNCTIVAL BIOPSY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LOCALIZATION; EOSINOPHIL; FEMALE; GIANT PAPILLARY CONJUNCTIVITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NASAL BIOPSY; NOSE MUCOSA; NOSE POLYP; ORAL BIOPSY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; VERNAL CONJUNCTIVITIS;

ADOLESCENT; ADULT; ASTHMA; CD4-POSITIVE T-LYMPHOCYTES; CHILD; COLLAGEN TYPE I; COLLAGEN TYPE III; CONJUNCTIVITIS, ALLERGIC; EOSINOPHILS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; MUCOUS MEMBRANE; NASAL POLYPS; ORGAN SPECIFICITY; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 34447519207     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2007.02732.x     Document Type: Article

References (41)

1. Maggi E, Biswas P, Del Prete G et al. Accumulation of Th-2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis. J Immunol 1991 146 : 1169 74.
2. Calder VL, Jolly G, Hingorani M et al. Cytokine production and mRNA expression by conjunctival T cell lines in chronic allergic eye diseases. Clin Exp Allergy 1999 29 : 1214 22.
3. Leonardi A, DeFranchis G, Zancanaro F, Crivellari G, Plebani M, Secchi AG. Identification of local Th2 and Th0 lymphocytes in vernal conjunctivitis using flow cytometry. Invest Ophthalmol Vis Sci 1999 40 : 3036 40.
4. Leonardi A, Tavolato M, Brun P, Plebani M, Abatangelo G, Secchi AG. Growth factors and collagen distribution in vernal keratoconjunctivitis. Invest Ophthalmol Vis Sci 2000 41 : 4175 81.
5. Key B Allergy and allergic diseases. Part I. N Engl J Med 2001 344 : 30 37.
6. Roche WR, Beasley R, Williams JH, Holgate ST. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989 1 : 520 4.
7. Bergeron C, Boulet LP. Structural changes in airway diseases: characteristics, mechanisms, consequences, and pharmacologic modulation. Chest 2006 129 : 1068 87.
8. Hamilos DL. Nasal polyps as immunoreactive tissue. Allergy Asthma Proc 1996 17 : 293 6.
9. Woessner JF Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991 5 : 2145 54.
10. Ries C, Petrides PE. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol Chem Hoppe-Seyler 1995 376 : 345 5.
11. Kelly EA, Jarjour NN. Role of matrix metalloproteinases in asthma. Curr Opin Pulm Med 2003 9 : 28 33.
12. Mautino G, Oliver N, Chanez P, Bousquet J, Capony F. Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. Am J Respir Cell Mol Biol 1997 17 : 583 91.
13. Vignola AM, Riccobono L, Mirabella A et al. Sputum metalloproteinase-9/ tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Am J Respir Crit Care Med 1998 158 : 1945 50.
14. Kelly EAB, Busse WW, Jarjour NN. Increased matrix metalloproteinases (MMP)-9 in the airway following allergen challenge. Am J Resp Crit Care Med 2000 162 : 1157 61.
15. Lechapt-Zalcman E, Coste A, d'Ortho MP et al. Increased expression of matrix metalloproteinases-9 in nasal polyps. J Pathol 2001 193 : 233 41.
16. Okada S, Kita H, George TJ, Gleich GJ, Leiferman KM. Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9. Am J Resp Mol Cell Biol 1997 17 : 519 28.
17. Ohno I, Ohtani H, Nitta Y et al. Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airway inflammation. Am J Resp Mol Cell Biol 1997 16 : 212 9.
18. Leonardi A, Brun P, Abatangelo G, Plebani M, Secchi AG. Tear levels and activity of matrix metalloproteinase (MMP)-1 and MMP-9 in vernal keratoconjunctivitis. Invest Ophthalmol Vis Sci 2003 44 : 3052 8.
19. Abu El-Asrar AM, Van Aelst I, Al-Mansouri S, Missotten L, Opnenakker G, Geboes K. Gelatinase B in vernal keratoconjunctivitis. Arch Ophthalmol 2001 119 : 1505 11.
20. Leonardi A. Vernal keratoconjunctivitis: pathogenesis and treatment. Prog Retin Eye Res 2002 21 : 319 39.
21. Global strategy for asthma management and prevention. Update from NHLB/WHO Workshop Report 1995. GINA, revised 2002, NIH Publication No. 02-3659, 2002.
22. Di Stefano A, Capelli A, Lusuardi M et al. Decreased T-lymphocyte infiltration in bronchial biopsies of subjects with severe chronic obstructive pulmonary disease. Clin Exp Allergy 2001 31 : 893 902.
23. Leonardi A, Abatangelo G, Cortivo R, Secchi AG. Collagen type I and III in vernal keratoconjunctivitis. Br J Ophthalmol 1995 79 : 482 5.
24. Lee YM, Kim SS, Kim HA et al. Eosinophil inflammation of nasal polyp tissue: relationships with matrix metalloproteinases, tissue inhibitor of metalloproteinase-1, and transforming growth factor-beta1. J Korean Med Sci 2003 18 : 97 102.
25. Ko FW, Diba C, Roth M et al. A comparison of airway and serum matrix metalloproteinase-9 activity among normal subjects, asthmatic patients, and patients with asthmatic mucus hypersecretion. Chest 2005 127 : 1919 27.
26. Wenzel SE, Balzar S, Cundall M, Chu HW. Subepithelial basement membrane immunoreactivity for matrix metalloproteinase 9: association with asthma severity, neutrophilic inflammation, and wound repair. J Allergy Clin Immunol 2003 111 : 1345 52.
27. Shaida A, Kenyon G, Devalia J, Davies RJ, MacDonald TT, Pender SL. Matrix metalloproteinases and their inhibitors in the nasal mucosa of patients with perennial allergic rhinitis. J Allergy Clin Immunol 2001 108 : 791 6.
28. Chen Y-S, Langhammer T, Westhofen M, Lorenzen J. Relationship between matrix metalloproteinases MMP-2, MMP-9, tissue inhibitor of metalloproeinases-1 and IL-5, IL-8 in nasal polyps. Allergy 2007 62 : 66 72.
29. Kessel A, Bishara R, Amital A et al. Increased plasma levels of matrix metalloproteinase-9 are associated with the severity of chronic urticaria. Clin Exp Allergy 2005 35 : 221 5.
30. Locati M, Deuschle U, Massardi ML et al. Analysis of the gene expression profile activated by the CC chemokine ligand 5/RANTES and by lipopolysaccharide in human monocytes. J Immunol 2002 168 : 3557 62.
31. Han Z, Junxu, Zhong N Expression of matrix metalloproteinases MMP-9 within the airways in asthma. Respir Med 2003 97 : 563 7.
32. Whitelock JM, Murdoch AD, Iozzo RV. The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin and heparanases. J Biol Chem 1996 271 : 10079 86.
33. Bradding P, Roberts JA, Britten KM et al. Interleukins (IL)-4, -5, -6 and TNF in normal and asthmatic airways: evidence for the human mast cell as an important source of these cytokines. Am J Respir Cell Mol Biol 1994 10 : 471 80.
34. Fisher GJ, Datta SC, Talwar HS et al. Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature 1996 379 : 335 9.
35. Profita M, Gagliardo R, Di Giorgi R et al. In vitro effects of flunisolide on MMP-9, TIMP-1, fibronectin, TGF-beta1 release and apoptosis in sputum cells freshly isolated from mild to moderate asthmatics. Allergy 2004 59 : 927 32.
36. Cundall M, Sun Y, Miranda C, Trudeau JB, Barnes S, Wenzel SE. Neutrophil-derived matrix metalloproteinase-9 is increased in severe asthma and poorly inhibited by glucocorticoids. J Allergy Clin Immunol 2003 112 : 1064 71.
37. Vignola AM, Riccobono L, Profita M et al. Effects of low doses of inhaled fluticasone propionate on inflammation and remodelling in persistent-mild asthma. Allergy 2005 60 : 1511 7.
38. Jain VV, Kitagaki K, Kline JN. CpG DNA and immunotherapy of allergic airway diseases. Clin Exp Allergy 2003 33 : 1330 5.
39. Miyazaki D, Liu G, Clark L, Ono SJ. Prevention of acute allergic conjunctivitis and late-phase inflammation with immunostimulatory DNA sequences. Invest Ophthalmol Vis Sci 2000 41 : 3850 5.
40. Cho JY, Miller M, McElwain K et al. Remodeling associated expression of matrix metalloproteinase 9 but not tissue inhibitor of metalloproteinase 1 in airway epithelium: modulation by immunostimulatory DNA. J Allergy Clin Immunol 2006 117 : 618 25.
41. Bruce C, Thomas PS. The effect of marimastat, a metalloprotease inhibitor, on allergen-induced asthmatic hyper-reactivity. Toxicol Appl Pharmacol 2005 205 : 126 32.